Previous issue | Volume 92 | ESPE2019 | Next issue

58th Annual ESPE

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

How Do I

How Do I Session 2

hrp0092hdi2.1 | How Do I Session 2 | ESPE2019

How do I…. Manage Micropenis in a Child

Bertelloni Silvano , Tyutyusheva Nina

Micropenis is defined as a penile length less than 2.5 SD below the mean value for a given age (eg, <2.5 cm at term). Nowadays, it should be also diagnosed in utero by sonography. The incidence of micropenis has been reported as 1.5/10.000 male infants in Usa, 5/1.442 in France and 18/2710 in Brazil, suggesting geographical differences or different assessment. Micropenis represents a clinical sign, that may be part of various clinical conditions, such as hypogonad...

hrp0092hdi2.2 | How Do I Session 2 | ESPE2019

How Do I Diagnose Growth Hormone Insensitivity

Walenkamp Marie-Jose

Classical growth hormone insensitivity (GHI) is caused by a defect of the growth hormone receptor and is characterized by severe postnatal growth failure, craniofacial disproportion, IGF-I deficiency and normal or elevated levels of growth hormone. This is a rare condition. With the development of new genetic techniques during the last two decades other monogenetic defects resulting in milder forms of GHI have been identified. These include genes involved in the GH-IGF-I axis:...

hrp0092hdi2.3 | How Do I Session 2 | ESPE2019

Management of an Asymptomatic Child with T1D and Transglutaminase Positivity

Frohlich-Reiterer Elke

The association between type 1 diabetes (T1D) and other autoimmune diseases is well known.The prevalence of celiac disease (CD) ranges from 1% to 10% among children and adolescents with T1D.The risk of associated CD is inversely and independently associated with age at diagnosis, with the greatest risk in those diagnosed with T1D before the age of 5 years. Classical symptoms of CD as poor growth, weight loss, gastrointestin...